口腔矫治器治疗轻度、中度和重度阻塞性睡眠呼吸暂停的疗效:一项Meta分析
该Meta分析纳入42项研究共2265例患者,评估口腔矫治器(舌保持器TRD和下颌前移装置MAD)在不同严重程度阻塞性睡眠呼吸暂停(OSA)中的疗效。结果显示轻、中、重度OSA的呼吸暂停低通气指数分别改善48%、67%和62%;轻度OSA中MAD与TRD疗效差异显著(58% vs 21%),中度和重度OSA中两者无显著差异。
要点
- 轻、中、重度OSA的AHI分别改善48%、67%和62%。
- 轻度OSA中MAD疗效58% vs TRD 21%,差异显著。
- 中度和重度OSA中MAD与TRD疗效无显著差异。
核心结论
- TRD和MAD均为中度和重度OSA的有效治疗。
- MAD对轻度OSA有效,TRD尚需进一步验证。
- 轻中度与重度OSA在嗜睡、ODI和LSAT方面获得相似改善。
研究设计与样本
- 系统检索PubMed/MEDLINE、Cochrane Library和Web of Science,截至2022年11月10日。
- 遵循PRISMA指南,由2名作者独立系统检索。
- 最终纳入42项研究,共2265例患者。
主要发现
- 轻度OSA的AHI改善48%(5.6),中度改善67%(14.92),重度改善62%(32.1)。
- 轻度OSA中MAD与TRD疗效差异显著(58% vs 21%)。
- 中度OSA中MAD与TRD疗效无显著差异(67% vs 66%)。
- 重度OSA中MAD与TRD疗效无显著差异(66% vs 51%)。
- 各组间Epworth嗜睡量表、氧减饱和度指数(ODI)和最低血氧饱和度(LSAT)无显著差异。
临床怎么用
- 原文结论认为TRD和MAD均为中度和重度OSA的有效治疗。
- 原文结论认为MAD对轻度OSA有效,TRD尚需进一步验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Oral appliances (OA) are the recommended first-line option for mild-to-moderate obstructive sleep apnea (OSA)-hypopnea. However, there is a lack of evidence to compare the effectiveness of OA in different severities of OSA. The purpose of this study was to investigate the therapeutic effects of preferred OA (tongue retention devices [TRD] and mandibular advancement device [MAD]) in different severities of OSA. DATA SOURCES: PubMed/MEDLINE, The Cochrane Library, and Web of Science. REVIEW METHODS: Concentrating on the efficacy of OA, 2 authors searched 3 databases up to November 10, 2022, independently and systematically, following the requirements and steps of the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. RESULTS: Ultimately, 42 studies with 2265 patients met the criteria for inclusion in OA. Overall, the apnea-hypopnea index improved by 48% (5.6), 67% (14.92), and 62% (32.1) in mild, moderate, and severe OSA, respectively. Subgroup analysis showed a significant difference between MAD and TRD efficacy in mild OSA (58% vs 21%). However, no significant difference was seen between MAD and TRD efficacy in moderate (67% vs 66%) and severe OSA (66% vs 51%). There was no significant difference across groups in the Epworth Sleepiness Scale, oxygen desaturation index (ODI), and lowest oxygen saturation (LSAT). CONCLUSION: Overall, both TRD and MAD are effective treatments for moderate and severe OSA. MAD is efficacious in mild OSA, while TRD requires further validation. Furthermore, mild-moderate and severe OSA received similar improvements in sleepiness, ODI, and LSAT. This study complements the evidence for the efficacy of OA.
引用
- Liao J, Shi Y, Gao X, et al. Efficacy of Oral Appliance for Mild, Moderate, and Severe Obstructive Sleep Apnea: A Meta-analysis. Otolaryngol Head Neck Surg. 2024. PMID: 38363016. doi:10.1002/ohn.676
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。